Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 41.60
+1.25 (3.10%)
May 13, 2025, 1:45 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 11.12 billion as of May 12, 2025. Its market cap has increased by 30.49% in one year.
Market Cap
11.12B
Enterprise Value
9.63B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
41.60
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 11.12B, a decrease of -39.65%. That is a compound annual growth rate of -12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 11.12B | 30.58% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.77% |
| Dec 30, 2022 | 14.27B | 47.83% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 194.78B |
| Hansoh Pharmaceutical Group Company | 140.92B |
| JD Health International | 117.99B |
| WuXi Biologics | 93.82B |
| Innovent Biologics | 86.44B |
| Alibaba Health Information Technology | 80.09B |
| Akeso | 75.71B |
| Sichuan Kelun-Biotech Biopharmaceutical | 71.46B |